Aperio Group’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$1.47M Sell
2,615
-408
-13% -$259K ﹤0.01% 1385
2020
Q3
$2.11M Buy
3,023
+688
+29% +$537K 0.01% 1092
2020
Q2
$1.85M Buy
2,335
+714
+44% +$538K 0.01% 1150
2020
Q1
$965K Buy
1,621
+327
+25% +$319K ﹤0.01% 1326
2019
Q4
$1.47M Buy
1,294
+356
+38% +$387K 0.01% 1237
2019
Q3
$1.12M Sell
938
-23
-2% -$35.1K ﹤0.01% 1338
2019
Q2
$1.58M Buy
961
+41
+4% +$70.9K 0.01% 1177
2019
Q1
$1.88M Buy
920
+173
+23% +$305K 0.01% 1060
2018
Q4
$960K Buy
747
+239
+47% +$367K ﹤0.01% 1333
2018
Q3
$960K Sell
508
-55
-10% -$114K ﹤0.01% 1428
2018
Q2
$1.15M Buy
563
+50
+10% +$114K 0.01% 1298
2018
Q1
$1.14M Buy
513
+12
+2% +$30.5K 0.01% 1245
2017
Q4
$1.16M Buy
501
+92
+22% +$187K 0.01% 1223
2017
Q3
$728K Buy
409
+23
+6% +$32.1K ﹤0.01% 1462
2017
Q2
$525K Buy
386
+38
+11% +$45.9K ﹤0.01% 1631
2017
Q1
$410K Buy
348
+48
+16% +$49K ﹤0.01% 1670
2016
Q4
$239K Buy
300
+24
+9% +$19.1K ﹤0.01% 1903
2016
Q3
$243K Buy
+276
New +$200K ﹤0.01% 1833
2015
Q4
Sell
-351
Closed -$389K 1990
2015
Q3
$389K Buy
351
+140
+66% +$255K ﹤0.01% 1437
2015
Q2
$461K Buy
211
+34
+19% +$69.3K ﹤0.01% 1371
2015
Q1
$276K Buy
+177
New +$234K ﹤0.01% 1625

Other funds holding BLUE

Aperio Group's BLUE Position: Q4 2020 in Review

Aperio Group reduced its bluebird bio (BLUE) stake by 13% in Q4 2020, selling an estimated $259K and leaving 2,615 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #1385.

Aperio Group first reported a position in BLUE in Q1 2015 and has held it in 21 quarters since. The position peaked at $2.11M in Q3 2020. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.

  • Aperio Group held 2,615 shares of bluebird bio worth $1.47M as of Q4 2020.
  • Aperio Group sold 408 bluebird bio shares in Q4 2020, an estimated $259K.
  • bluebird bio made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1385 holding.
  • Aperio Group first reported a position in bluebird bio in Q1 2015 and has held it in 21 quarters since.
  • Aperio Group's bluebird bio position peaked at $2.11M in Q3 2020.
  • 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.